908 Devices (MASS) Net Margin (2020 - 2026)

908 Devices' (MASS) quarterly Net Margin came in at 111.18% in Q1 2026, down 56495.0% year-on-year from N/an in Q1 2025, and down 9372.1% on a QoQ basis from 1.17% in Q4 2025.

908 Devices (MASS) Net Margin (2020 - 2026) Analysis & Trends

908 Devices (MASS) has 7 years of Net Margin data on file, last reported at 111.18% in Q1 2026.

  • On a quarterly basis, Net Margin fell 56495.0% year-over-year to 111.18% in Q1 2026; TTM through Mar 2026 was 26.9%, a 10252.0% decrease from a year earlier, with the FY2025 full-year figure at 93.89%, up 13383.0% from the prior year.
  • Net Margin for Q1 2026 stood at 111.18%, down from 1.17% in the prior quarter.
  • Over the last five years, Net Margin for MASS reached as high as 453.77% in Q1 2025 and fell as low as 132.1% in Q1 2023.
  • Historically, Net Margin has averaged 27.76% across 5 years, with a median of 49.61% in 2023.
  • Across the five-year window, Net Margin surged 52143 bps in 2025 and plunged 56495 bps in 2026, its largest moves.
  • Year by year, Net Margin stood at 84.09% in 2022, then soared by 38 bps to 51.77% in 2023, then jumped by 54 bps to 23.86% in 2024, then surged by 95 bps to 1.17% in 2025, then tumbled by 9372 bps to 111.18% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 111.18% in Q1 2026, 1.17% in Q4 2025, and 0.51% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.65%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.38%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 12.84%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 16.74%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.01%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 908 Devices 261.78 Mn 150.04 Mn 6.88 Mn -111.18%

Historic Data

Download Data
DateValue
Mar 31, 2026 -111.18%
Dec 31, 2025 -1.17%
Sep 30, 2025 -0.51%
Jun 30, 2025 -3.05%
Mar 31, 2025 453.77%
Dec 31, 2024 -23.86%
Sep 30, 2024 -38.89%
Jun 30, 2024 -43.40%
Mar 31, 2024 -67.66%
Dec 31, 2023 -51.77%
Sep 30, 2023 -49.61%
Jun 30, 2023 -77.28%
Mar 31, 2023 -132.10%
Dec 31, 2022 -84.09%
Sep 30, 2022 -39.62%
Jun 30, 2022 -72.92%
Mar 31, 2022 -128.57%
Dec 31, 2021 -46.87%
Sep 30, 2021 -41.33%
Jun 30, 2021 -102.03%